Alexander O. Konig

Goettingen, NI, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Model substrate particles uncover dynamics of microbial communities associated with particulate organic matter decomposition in soil.

Model substrate particles uncover dynamics of microbial communities associated with particulate organic matter decomposition in soil.

Journal: ISME communications

Published: August 04, 2025

FLOT Versus CROSS-What Is the Optimal Therapeutic Approach for Locally Advanced Adenocarcinoma of the Esophagus and the Esophagogastric Junction?

FLOT Versus CROSS-What Is the Optimal Therapeutic Approach for Locally Advanced Adenocarcinoma of the Esophagus and the Esophagogastric Junction?

Journal: Cancers

Published: May 27, 2025

Safety and efficacy of add-on robotic therapy for early mobilization in intermediate neurocritical care: a pilot study.

Safety and efficacy of add-on robotic therapy for early mobilization in intermediate neurocritical care: a pilot study.

Journal: Journal of neuroengineering and rehabilitation

Published: May 08, 2025

A Concept for Mining Transitive Sequential Patterns from Pancreatic Cancer Patient Journeys.

A Concept for Mining Transitive Sequential Patterns from Pancreatic Cancer Patient Journeys.

Journal: Studies in health technology and informatics

Published: September 05, 2024

Impact of Portal Vein Resection (PVR) in Patients Who Underwent Curative Intended Pancreatic Head Resection.

Impact of Portal Vein Resection (PVR) in Patients Who Underwent Curative Intended Pancreatic Head Resection.

Journal: Biomedicines

Published: August 20, 2023

Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with fluorouracil and folinic acid with or without panitumumab as maintenance therapy: a prespecified secondary analysis of the PanaMa (AIO KRK 0212) trial.

Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with fluorouracil and folinic acid with or without panitumumab as maintenance therapy: a prespecified secondary analysis of the PanaMa (AIO KRK 0212) trial.

Journal: European journal of cancer (Oxford, England : 1990)

Published: May 04, 2023

Prognostic and predictive impact of metastatic organ involvement on maintenance therapy in advanced metastatic colorectal cancer: Subgroup analysis of patients treated within the PanaMa trial (AIO KRK 0212).

Prognostic and predictive impact of metastatic organ involvement on maintenance therapy in advanced metastatic colorectal cancer: Subgroup analysis of patients treated within the PanaMa trial (AIO KRK 0212).

Journal: International journal of cancer

Published: March 09, 2023

Predictors of lower exercise capacity in patients with cancer.

Predictors of lower exercise capacity in patients with cancer.

Journal: Scientific reports

Published: February 23, 2023

Testing robot-based assist-as-needed therapy for improving active participation of a patient during early neurorehabilitation: a case study.

Testing robot-based assist-as-needed therapy for improving active participation of a patient during early neurorehabilitation: a case study.

Journal: IEEE ... International Conference on Rehabilitation Robotics : [proceedings]

Published: September 30, 2022

Depth of response of induction therapy and consecutive maintenance treatment in patients with RAS wild-type metastatic colorectal cancer: An analysis of the PanaMa trial (AIO KRK 0212).

Depth of response of induction therapy and consecutive maintenance treatment in patients with RAS wild-type metastatic colorectal cancer: An analysis of the PanaMa trial (AIO KRK 0212).

Journal: European journal of cancer (Oxford, England : 1990)

Published: August 09, 2022

Cardiovascular and metabolic determinants of quality of life in patients with cancer.

Cardiovascular and metabolic determinants of quality of life in patients with cancer.

Journal: ESC heart failure

Published: May 16, 2022

Enhancer of Zeste Homolog 2 (EZH2) Is a Marker of High-Grade Neuroendocrine Neoplasia in Gastroenteropancreatic and Pulmonary Tract and Predicts Poor Prognosis.

Enhancer of Zeste Homolog 2 (EZH2) Is a Marker of High-Grade Neuroendocrine Neoplasia in Gastroenteropancreatic and Pulmonary Tract and Predicts Poor Prognosis.

Journal: Cancers

Published: March 10, 2022

Showing 1-12 of 19

Last Updated: 09/26/2026